Sutro Biopharma, Inc 10-Q for FY2021 Q2
Sutro Biopharma, Inc. (STRO)
10-Q
2021-08-09
For: 2021-06-30
View Original
Added on
April 11, 2026
About this 10-Q
Sutro Biopharma, Inc filed this 10-Q on August 9, 2021, covering the quarter ended June 30, 2021 (FY2021 Q2).
Headline figures
Quarter ended June 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $28.05M
- up 196.2% from $9.47M a year earlier
- Net loss
- $6.15M
- compared with net income of $29.87M a year earlier
- Diluted EPS
- -$0.13
- compared with $0.94 a year earlier